Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
COR120 - Comprehensive Pharmacogenetic Test Quantigen Laboratory Quantigen LLC United States | 108 | 10 |
|
SmartMeds+ Pharmacogenomic Testing By Innovative GX Health Innovative Genomics InnovativeGx Health United States | 1 | 67 |
|
Dynamic DNA Laboratories, LLC United States | 33 | 8 |
|
Dynamic DNA Laboratories, LLC United States | 59 | 8 |
|
Precision HealthPGx Panel (25 Genes) RPRD Diagnostics, LLC United States | 97 | 23 |
|
RPRD Diagnostics, LLC United States | 107 | 69 |
|
OneOme, LLC United States | 6 | 15 |
|
Genomind Pharmacogenetic Report Genomind, Inc. Genomind, Inc United States | 14 | 27 |
|
Assurex Health, Inc. United States | 6 | 14 |
|
Dynamic DNA Laboratories, LLC United States | 125 | 18 |
|
Genetic study of pharmacogenetics HeartGenetics, Genetics and Biotechnology, SA Portugal | 1 | 26 |
|
Tempus Labs, Inc. United States | 4 | 13 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 3 | 1 |
|
Tempus Labs, Inc. United States | 2 | 647 |
|
SPMED CO., LTD Step forward Personalized Medicine South Korea | 51 | 26 |
|
PGx-Premium (Preemptive PGx test) SPMED CO., LTD Step forward Personalized Medicine South Korea | 66 | 27 |
|
SPMED CO., LTD Step forward Personalized Medicine South Korea | 5 | 3 |
|
OmniSeq, Inc. United States | 1 | 525 |
|
Polypharmacy Comprehensive Panel Invitae United States | 33 | 24 |
|
Synovitis, chronic, susceptibility to (HLA-B gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.